Hiroaki Yamagami

Tokyo, 1378610, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Elderly patient with unresectable advanced‑stage hepatocellular carcinoma who received atezolizumab plus bevacizumab and achieved a complete response: A case report.

Elderly patient with unresectable advanced‑stage hepatocellular carcinoma who received atezolizumab plus bevacizumab and achieved a complete response: A case report.

Journal: Medicine international

Published: January 13, 2024

Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis.

Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis.

Journal: Reports (MDPI)

Published: October 26, 2023

Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan.

Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan.

Journal: Medicina (Kaunas, Lithuania)

Published: July 17, 2023

COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.

COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.

Journal: In vivo (Athens, Greece)

Published: March 20, 2022

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.

Journal: Journal of clinical medicine

Published: November 09, 2021

Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series.

Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series.

Journal: Anticancer research

Published: September 08, 2021

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2021

Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.

Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 11, 2021

Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan.

Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan.

Journal: Viruses

Published: January 07, 2021

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease.

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease.

Journal: International journal of medical sciences

Published: February 19, 2019

Apoptosis and non-alcoholic fatty liver diseases.

Apoptosis and non-alcoholic fatty liver diseases.

Journal: World journal of gastroenterology

Published: April 03, 2018

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.

Journal: World journal of gastroenterology

Published: October 13, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026